Intravenous Immune Globulin Therapy for Neurologic Diseases
Ann Int Med 126:721-730, Dalakas,M.C., 1997
Neurologic Complications Associated with the Zika Virus in Brazilian Adults
JAMA Neurol 74:1190-1198,1164, Ferreira da Silva, I.R.,et al, 2017
Chronic Inflammatory Demyelinating Polyneuropathy Presenting with Features of GBS
Neurol 58:979-982, Mori,K.,et al, 2002
CIDP:Clinical Features & Responses to Trtm in 67 Consecutive Pts with/without a Monoclonal Gammopathy
Neurol 48:321-328, Gorson,K.G.,et al, 1997
Neurologic Manifestations of HIV Infection
Ann Int Med 121:769-785, Simpson,D.M.&Tagliati,M., 1994
Nerve Root Enhancement with MRI in Inflammatory Demyelinating Polyradiculoneuropathy
Neurol 32:618-619, Morgan,G.W.,et al, 1993
Recurrent Aseptic Meningitis Complicating Intravenous Immunoglobulin Therapy for CIDP
Neurol 42:1636-1637, Vera-Ramirez,M.,et al, 1992
Duplication of Part of Chromosome 17 is Commonly Associated with HMSN Type I (Charcot-Marie-Tooth Disease Type 1)
Ann Neurol 31:570-572, Hallam,P.J.,et al, 1992
Clinical Uses of Intravenous Immunoglobulins
Ann Int Med 112:278-292, Berkman,S.A.,et al, 1990
Treatment of Peripheral Neuropathies
JNNP 48:1193-1207, Hallett,M.,et al, 1985
A 64-Year-Old Man with Multiple Cranial Neuropathies
Neurol 97:e215-e221, Lefland, A.,et al, 2021
A 57-Year-Old Woman with Progressive Ataxia and Falls
Neurol 95:650-656, Badahdah, A., 2020
Clinical Reasoning: A 49-year-old man with Progressive Numbness, Weakness, and Evidence of Leptomeningeal Enhancement
Neurol 90:e90-e93, Lovett, A.,et al, 2018
Evidence-based Guideline: Intravenous Immunoglobulin in the Treatment of Neuromascular Disorders
Neurol 78:1009-1015, Patwa,H.S.,et al, 2012
Spectrum of Paraneoplastic Disease Associated With Lymphoma
Neurol 76:705-710, Briani,C.,et al, 2011
Evidence-Based Guideline Update: Plasmapheresis in Neurologic Disorders: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
Neurol 76:294-300, Cortese,I.,et al, 2011
Hypertrophic Nerves Producing Myelopathy in Fulminant CIDP
Neurol 75:750, Staff,N.P.,et al, 2010
Monoclonal Antibody Therapies and Neurologic Disorders
Arch Neurol 65:1162-1165, Novack,J.C.,et al., 2008
Plasma Exchange in Neuroimmunological Disorders: Part 2. Treatment of Neuromuscular Disorders
Arch Neurol 63:1066-1071, Lehmann,H.C.,et al, 2006
Treatment of Chronic Inflamatory Demyelinating Polyneuropathy With High-Dose Intermittent Intravenous Methylprednisolone
Arch Neurol 62:249-254, Lopate, G., et al, 2005
Chronic Inflammatory Demyelinating Polyradiculoneuropathy: MRI Study of Brain and Spinal Cord
Neurol 64:914-916, Laura, M., et al, 2005
Chronic Inflammatory Demyelinating Polyneuropathy
NEJM 352:1343-1356, Koller,H.,et al, 2005
Intravenous Immunoglobulin in Autoimmune Neuromuscular Diseases
JAMA 291:2367-2375, Dalakas,M.C., 2004
Clinicopath Conf., Chronic Inflammatory Demyelinating Polyneuropathy
NEJM 348:735-743, Case 6-2003, 2003
Randomized Controlled Trial of Intravenous Immunoglobulin Versus Oral Prednisolone in Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Ann Neurol 50:195-201, Hughes,R.,et al, 2001
Intravenous Immunoglobulin Treatment in Neurologic Disorders
Arch Neurol 56:1025-1027,1032, Sorensen,P.S., 1999
Is the Routine Use of Intravenous Immunoglobulin Treatment in Neurologic Disorders Justified?
Arch Neurol 56:1028-1032, Karussis,D.&Abramsky,O., 1999
Hypertrophy of Multiple Cranial Nerves and Spinal Roots in Chronic Inflammatory Demyelinating Neuropathy
JNNP 67:685-687, Duarte,J.,et al, 1999
Intravenous Immunoglobulin in the Treatment of Autoimmune Neuromuscular Diseases:Present Status and Practical Therapeutic Guidelines
Muscle & Nerve 22:1479-1497, Dalakas,M.C., 1999
Hypertrophic Neuritis Due to Chronic Inflammatory Demyelinating Polyradiculoneuropathy:Postmortem Path Study
Muscle & Nerve 19:163-169996., Matsuda,M.,et al, 1996
Intravenous Immunoglobulin Treatment of Neurological Disease
JNNP 60:359-361, Otten,A.,et al, 1996
Chronic Inflammatory Demyelinating Polyradiculoneuropathy:Unusual Clinical Features and Therapeutic Responses
Neurol 46:1206-1212, Midroni,G.&Dyck,P.J., 1996
Massive Nerve Root Enlargement in Chronic Inflammatory Demyelinating Polyneuropathy
JNNP 61:636-640, Schady,W.,et al, 1996
Multifocal Demyelinating Motor Neuropathy:Pathologic Evidence of Inflammatory Demyelinasting Polyradiculoneuropathy
Neurol 45:1828-1832, Oh,S.J.,et al, 1995
Plasma Exchange and Intravenous Immunoglobulin Treatment of Neuromuscular Disease
Ann Neurol 35:260-268, Thornton,C.A.&Griggs,R.C., 1994
Magnetic Resonance Imaging of the Cauda Equina in Chronic Inflammatory Demyelinating Polyneuropathy
Ann Neurol 33:311-313, Crino,P.B.,et al, 1993
Acute Neuromuscular Respiratory Paralysis
JNNP 56:334-343, Hughes,R.A.C.&Bihari,D., 1993
Differential Diagnosis of Guillain-Barre Synd, In Guillain-Barre Synd
Thieme Med Publ, Ch 3, p 42993., Parry,G.J., 1993
Subacute Idiopathic Demyelinating Polyradiculoneuropathy
Arch Neurol 49:612-616, Hughes,R.,et al, 1992
Immunologic Aspects of Neurological and Neuromuscular Diseases
JAMA 268:2918-2922, Zweiman,B.&Levinson,A.I., 1992
AIDS and the Nervous System
JAMA 261:2396-2399, Dalakas,M.,et al, 1989
Neuromuscular Diseases Associated with Human Immunodeficiency Virus Infection
Ann Neurol 23:S38-S48, Dalakas,M.C.&Pezeshkpour,G.H., 1988
Chronic Inflammatory Demyelinating Polyradiculoneuropathy Associated with Pregnancy
Ann Neurol 21:102-104, McCombe,P.A.,et al, 1987